Detalles de la búsqueda
1.
Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology.
Int J Clin Oncol;
2024 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38578596
2.
Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
Int J Clin Oncol;
2024 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38649648
3.
Perspectives for the clinical application of ctDNA analysis to breast cancer drug therapy.
Breast Cancer;
2024 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38649655
4.
Prognostic value of serum tartrateresistant acid phosphatase5b for bone metastasis in patients with resectable breast cancer.
Oncol Lett;
27(6): 250, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38638841
5.
Real-world progression-free survival and overall survival of palbociclib plus endocrine therapy (ET) in Japanese patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer in the first-line or second-line setting: an observational study.
Breast Cancer;
2024 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38642245
6.
High HER2 Intratumoral Heterogeneity Is a Predictive Factor for Poor Prognosis in Early-Stage and Locally Advanced HER2-Positive Breast Cancer.
Cancers (Basel);
16(5)2024 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38473420
7.
Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022.
Int J Clin Oncol;
29(5): 545-550, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38517658
8.
Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
Int J Clin Oncol;
29(5): 551-558, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38526621
9.
Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022.
Int J Clin Oncol;
29(5): 559-563, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38538963
10.
Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022.
Int J Clin Oncol;
29(4): 355-362, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38353907
11.
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition.
Breast Cancer;
30(6): 872-884, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37804479
12.
Evaluation of RASSF1A methylation in the lysate of sentinel lymph nodes for detecting breast cancer metastasis: A diagnostic accuracy study.
Oncol Lett;
26(5): 475, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37809046
13.
Detection of high-risk patients resistant to CDK4/6 inhibitors with hormone receptor-positive HER2-negative advanced and metastatic breast cancer in Japan (KBCSG-TR-1316).
Breast Cancer;
30(6): 943-951, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37486454
14.
Phase II trial of biweekly administration with eribulin after three cycles of induction therapy in hormone receptor-positive, HER2-negative metastatic breast cancer (JACCRO BC-03).
Breast Cancer Res Treat;
201(3): 409-415, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37480384
15.
Real-world data analysis of perioperative chemotherapy patterns, G-CSF use, and FN status in patients with early breast cancer.
Breast Cancer Res Treat;
201(2): 265-273, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37410318
16.
Detection of Ultra-Rare ESR1 Mutations in Primary Breast Cancer Using LNA-Clamp ddPCR.
Cancers (Basel);
15(9)2023 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37174098
17.
Hypercalcemia affected in metastatic breast cancer patients without bone metastasis: report of three cases.
Surg Case Rep;
8(1): 210, 2022 Nov 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36435947
18.
Pertuzumab retreatment for HER2-positive advanced breast cancer: A randomized, open-label phase III study (PRECIOUS).
Cancer Sci;
113(9): 3169-3179, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35754298
19.
Proton Pump Inhibitors Ameliorate Capecitabine-induced Hand-Foot Syndrome in Patients With Breast Cancer: A Retrospective Study.
Anticancer Res;
42(5): 2591-2598, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35489750
20.
A case of sternal osteomyelitis during treatment with everolimus for recurrent breast cancer.
Surg Case Rep;
8(1): 23, 2022 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35089453